Regulatory Compliance

United States – October 12, 2026 -- S-Docs, a document automation and e-Signature provider, has received FedRAMP attestation, opening a path to expand with U.S. government agencies and the wider public sector.

FedRAMP status targets security-sensitive public-sector buyers

FedRAMP is the U.S. government's standardized framework for validating the security of cloud platforms that process sensitive, data-heavy workloads. It lets agencies adopt advanced cloud and AI capabilities with speed and confidence.

S-Docs says the attestation lets it grow its footprint with U.S. government agencies and the public sector. It also lays the groundwork for partnerships with other security-conscious organizations.

New York City – October 12, 2026 -- S-Docs has achieved SOC 2 Type II compliance for its HubSpot product, passing an independent audit of how it safeguards customer data over an extended period.

The assessment, developed by the American Institute of Certified Public Accountants (AICPA), tests whether security controls are well-designed and consistently operating in practice. It draws on the AICPA's Trust Services Criteria: security, availability, processing integrity, confidentiality and privacy.

Audit covered six control areas at S-Docs

The audit included control testing and operational analysis across security monitoring, access controls, incident response, disaster recovery, business continuity and internal risk management. S-Docs says the results confirm repeatable security practices in its day-to-day operations.

New York City – October 12, 2026 -- S-Docs, a 100% Salesforce-native document automation vendor, has added Common Access Card (CAC) and Personal Identity Verification (PIV) authenticated signing to its S-Sign e-Signature product, letting agencies and contractors verify signer identity inside Salesforce workflows.

S-Sign verifies signer identity at the moment of document execution

The enhancement uses the signer's existing identity provider. Agencies and contractors insert their CAC or PIV cards to authenticate, without replacing or reworking established systems. S-Docs describes the product as fully standards-based and identity-provider-agnostic.

S-Docs says the enhanced S-Sign runs entirely within Salesforce and requires no extra clicks or downloads. It meets DoD and federal requirements guided by NIST and FIPS standards and keeps a complete audit trail for compliance and record-keeping.

New York City – October 12, 2026 -- S-Docs, a document automation platform built 100% natively on Salesforce, has been named "Best Contract Management Software" in the 2026 MarTech Breakthrough Awards, after adding CAC and PIV-authenticated signing to its e-Signature capabilities.

S-Docs targets contract inefficiency that costs up to 9% of annual revenue

The company cites inefficiencies in contract management as costing organizations up to 9% of annual revenue, driven by delays, errors and missed obligations. It also points to disconnected systems and weak identity verification as sources of compliance gaps and security vulnerabilities.

New York City – – October 12, 2026 -- Among regulated organizations that report financial damage from document workflow failures, 21% put the cost at $500,000 or more, according to a new S-Docs report, The Regulated Workflow Divide. The survey of 600 U.S. professionals in healthcare, financial services and the public sector also found that about 50% of organizations expose sensitive data outside their system of record.

Fragmented tooling drives much of the exposure. Some 69% of organizations route critical documents through three or more tools, and 76% use more than one tool for the same document-related function. Employees lose roughly 25% of their workweek re-entering data, reformatting documents and compensating for disconnected systems.

New York City – October 12, 2026 -- S-Docs, a document automation and e-Signature provider for Salesforce, has expanded its platform to let regulated enterprises build templates without code, collect signatures in the same workflow as document generation, and let AI assistants initiate document requests under Salesforce governance.

The launch targets a governance gap the company cites: 72% of regulated organizations have deployed AI in at least one document workflow, but only 30% have the governance to do so safely.

Visual Template Editor removes the admin and developer bottleneck

The new Visual Template Editor lets business users design documents on a page, see changes live, and add Salesforce data and conditional logic without writing code. Template creation previously required an admin or a developer. S-Docs says any trained team member can now do it, shortening the time to launch or update a document.

DUBLIN – October 12, 2026 -- AerCap Holdings N.V. (NYSE: AER) has filed its interim financial report for the quarter ended June 30, 2026, with the U.S. Securities and Exchange Commission, including unaudited condensed consolidated financial statements and notes.

AerCap submits the second-quarter filing on Form 6-K

The report was filed as a Form 6-K. It is available in the Investors section of AerCap's website and on the SEC's website. The announcement itself contained no revenue, earnings or fleet figures; those details sit in the filing.

AerCap lists sanctions, tariffs and rates among the risks to its results

The company's forward-looking statements name the continued impact of the Ukraine conflict as a risk, including sanctions imposed by the United States, the European Union, the United Kingdom and other countries. They also cite hostilities in the Middle East and any escalation of them.

Calgary – October 12, 2026 -- XORTX Therapeutics (NASDAQ: XRTX | TSXV: XRTX) has appointed Mika Grasso, 28, as co-CEO responsible for finance and public markets, and says it aims to advance its lead gout program, XRx-026, toward marketing approval over the next 18 months.

The company says the appointment follows a recent financing and growing investor interest. It is now restructuring its corporate and issuer status, re-initiating drug development programs and preparing regulatory filings for XRx-026. Risk disclosures in the release also refer to a voluntary delisting that may not be completed on the anticipated timeline, or at all.

Calgary – October 12, 2026 -- XORTX Therapeutics (NASDAQ: XRTX) plans to submit an Investigational New Drug application to the U.S. FDA in the fourth quarter of 2026 for its XRx-026 gout program, and estimates the program addresses a US$700M annual market opportunity.

XORTX targets an NDA filing in about one year, contingent on funding

The IND describes the company's clinical development plan for XORLOTM, its proprietary oxypurinol formulation, and its intention to file a New Drug Application after completing the two-part XRX-OXY-102 clinical trial. The trial is designed to characterize the pharmacokinetics and efficacy information the FDA needs to evaluate a future NDA.

Fort Wayne – October 12, 2026 -- Indiana Michigan Power (I&M) has asked the Indiana Utility Regulatory Commission (IURC) to approve a 1,520 megawatt (MW) natural gas combined cycle plant at its Rockport site, one of the largest utility construction projects in Indiana.

I&M expects power demand in its Indiana service area to more than double by the early 2030s. The new Rockport Energy Center is meant to add generation capacity to meet that load.

I&M targets summer 2030 start-up, with an IURC ruling expected in early 2027

I&M filed for a certificate of public convenience and necessity (CPCN). The filing details the construction timeline, the allocation of construction and operating costs, regional transmission capacity and environmental factors.

The company anticipates an IURC decision in early 2027. Construction would begin in 2027, and the plant is expected to be operational in summer 2030.